|
|
| Line 1: |
Line 1: |
| {{Colesevelam}}
| |
| __NOTOC__ | | __NOTOC__ |
| {{CMG}}; {{AE}} {{SS}} | | {{CMG}}; {{AE}} {{SS}} |
| Line 13: |
Line 12: |
| ==Category== | | ==Category== |
|
| |
|
| Cardiovasuclar Drugs:Bile acid sequestrants
| | Bile acid sequestrant |
|
| |
|
| ==FDA Package Insert== | | ==Prescribing Information== |
|
| |
|
| ''' [[Colesevelam indications and usage|Indications and Usage]]''' | | ===''[[Colesevelam hydrochloride|Colesevelam hydrochloride]]''=== |
| '''| [[Colesevelam dosage and administration|Dosage and Administration]]'''
| |
| '''| [[Colesevelam dosage forms and strengths|Dosage Forms and Strengths]]'''
| |
| '''| [[Colesevelam contraindications|Contraindications]]'''
| |
| '''| [[Colesevelam warnings and precautions|Warnings and Precautions]]'''
| |
| '''| [[Colesevelam adverse reactions|Adverse Reactions]]'''
| |
| '''| [[Colesevelam drug interactions|Drug Interactions]]'''
| |
| '''| [[Colesevelam use in specific populations|Use in Specific Populations]]'''
| |
| '''| [[Colesevelam overdosage|Overdosage]]'''
| |
| '''| [[Colesevelam description|Description]]'''
| |
| '''| [[Colesevelam clinical pharmacology|Clinical Pharmacology]]'''
| |
| '''| [[Colesevelam nonclinical toxicology|Nonclinical Toxicology]]'''
| |
| '''| [[Colesevelam clinical studies|Clinical Studies]]'''
| |
| '''| [[Colesevelam how supplied storage and handling|How Supplied/Storage and Handling]]'''
| |
| '''| [[Colesevelam patient counseling information|Patient Counseling Information]]'''
| |
| '''| [[Colesevelam labels and packages|Labels and Packages]]'''
| |
|
| |
|
| ==Mechanism of Action==
| | * [[Welchol]] |
|
| |
|
| ==References==
| |
|
| |
| {{Reflist|2}}
| |
| {{Lipid modifying agents}} | | {{Lipid modifying agents}} |
|
| |
| [[Category:Hepatology]]
| |
| [[Category:Bile acid sequestrants]]
| |
| [[Category:Cardiovasuclar Drugs]]
| |
| [[Category:Drugs]]
| |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]
For patient information about Colesevelam, click here.
Synonyms / Brand Names: Welchol®
Overview
Colesevelam is a bile acid sequestrant administered orally. It is developed by Genzyme and marketed in the US by Daiichi Sankyo under the brand name Welchol and elsewhere by Genzyme as Cholestagel. In Canada it is marketed by Valeant as Lodalis.
Category
Bile acid sequestrant
Prescribing Information
Template:Lipid modifying agents